Cargando…
Treatment utilization and treatment barriers in individuals with body dysmorphic disorder
BACKGROUND: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical character...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027080/ https://www.ncbi.nlm.nih.gov/pubmed/32070300 http://dx.doi.org/10.1186/s12888-020-02489-0 |
_version_ | 1783498795235934208 |
---|---|
author | Schulte, Johanna Schulz, Claudia Wilhelm, Sabine Buhlmann, Ulrike |
author_facet | Schulte, Johanna Schulz, Claudia Wilhelm, Sabine Buhlmann, Ulrike |
author_sort | Schulte, Johanna |
collection | PubMed |
description | BACKGROUND: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical characteristics. METHODS: German individuals completed an online self-report survey of appearance concerns. A sample of N = 429 individuals met criteria for BDD. We examined the frequency of treatment utilization and barriers, analyzed comparisons between treated and untreated individuals and assessed the relationships of socio-demographic and clinical features with mental health treatment utilization and treatment barriers, respectively. RESULTS: Only 15.2% of the individuals with BDD had been diagnosed with BDD, and lifetime rates of mental health treatment were low (39.9%). Individuals endorsed multiple barriers to mental health treatment, especially shame, low perceived need and a preference for cosmetic and medical treatments. Associated features were identified, including age, a BDD diagnosis, body dysmorphic symptom severity, a likely major depressive disorder, prior cosmetic surgery, and insight. CONCLUSIONS: The results of this largest study to date highlight that BDD is still underrecognized and undertreated even in a country with extensive mental health care and few financial barriers. We discuss modifiable factors and strategies to foster awareness of BDD in sufferers and professionals to improve treatment dissemination and to reduce treatment barriers. |
format | Online Article Text |
id | pubmed-7027080 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-70270802020-02-24 Treatment utilization and treatment barriers in individuals with body dysmorphic disorder Schulte, Johanna Schulz, Claudia Wilhelm, Sabine Buhlmann, Ulrike BMC Psychiatry Research Article BACKGROUND: Although effective treatments are available, most individuals with body dysmorphic disorder (BDD) do not receive an appropriate diagnosis or treatment. We aimed to examine treatment utilization and barriers to treatment, and to identify associated socio-demographic and clinical characteristics. METHODS: German individuals completed an online self-report survey of appearance concerns. A sample of N = 429 individuals met criteria for BDD. We examined the frequency of treatment utilization and barriers, analyzed comparisons between treated and untreated individuals and assessed the relationships of socio-demographic and clinical features with mental health treatment utilization and treatment barriers, respectively. RESULTS: Only 15.2% of the individuals with BDD had been diagnosed with BDD, and lifetime rates of mental health treatment were low (39.9%). Individuals endorsed multiple barriers to mental health treatment, especially shame, low perceived need and a preference for cosmetic and medical treatments. Associated features were identified, including age, a BDD diagnosis, body dysmorphic symptom severity, a likely major depressive disorder, prior cosmetic surgery, and insight. CONCLUSIONS: The results of this largest study to date highlight that BDD is still underrecognized and undertreated even in a country with extensive mental health care and few financial barriers. We discuss modifiable factors and strategies to foster awareness of BDD in sufferers and professionals to improve treatment dissemination and to reduce treatment barriers. BioMed Central 2020-02-18 /pmc/articles/PMC7027080/ /pubmed/32070300 http://dx.doi.org/10.1186/s12888-020-02489-0 Text en © The Author(s) 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Schulte, Johanna Schulz, Claudia Wilhelm, Sabine Buhlmann, Ulrike Treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
title | Treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
title_full | Treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
title_fullStr | Treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
title_full_unstemmed | Treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
title_short | Treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
title_sort | treatment utilization and treatment barriers in individuals with body dysmorphic disorder |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027080/ https://www.ncbi.nlm.nih.gov/pubmed/32070300 http://dx.doi.org/10.1186/s12888-020-02489-0 |
work_keys_str_mv | AT schultejohanna treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder AT schulzclaudia treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder AT wilhelmsabine treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder AT buhlmannulrike treatmentutilizationandtreatmentbarriersinindividualswithbodydysmorphicdisorder |